Delayed treatment effect predicting (DTEP) model found to enhance precision in immuno-oncology trial designs
Over the last decade, immunotherapies, particularly immune checkpoint inhibitors (ICIs), have emerged as promising treatments for various cancer types. However, a notable challenge in immuno-oncology trials is the frequent ...